Researcher Biographies
The ICR’s impressive record of achievement over the past 100 years is largely due to the commitment of its outstanding scientific staff. To find out more about the ICR's world-leading researchers, click on the names listed in alphabetical order below or on the right. Each profile contains details of the scientist's background, research and clinical specialities, current projects and personal interests.
Dr Gert Attard
Academic Clinical Lecturer and Drug Development Unit member
Developing new prostate cancer drugs, including abiraterone
Dr Chris Bakal
Dynamical Cell Systems Team Leader
Studying shape changes that allow cancerous cells to spread
Dr Udai Banerji
Clinical Senior Lecturer in Medical Oncology
Designing and supervising patient trials
Dr Louis Chesler
Neuroblastoma Drug Development Team Leader
Investigating new drug targets for childhood cancers
Professor Colin Cooper
Director of the Everyman centre
Improving diagnosis, treatment and awareness of male cancers
Professor David Dearnaley
Professor of Uro-Oncology
Improving radiotherapy techniques and caring for patients with urological cancer
Dr Johann de Bono
Senior Lecturer and Honorary Consultant in Medical Oncology
Developing targeted drugs, including the new prostate and breast cancer therapy abiraterone
Professor Nandita deSouza
Co-director of the Cancer Research UK and EPSRC Cancer Imaging Centre at The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust
Setting the standard for MRI use in patient care
Dr Ros Eeles
Reader in Clinical Cancer Genetics and Honorary Consultant in Clinical Oncology and Cancer Genetics
Bringing cancer genetics research from the bench to the bedside
Dr Janine Erler
Hypoxia and Metastasis Team Leader
Identifying factors that influence cancer spread, including the LOX enzyme
Professor Mel Greaves
Chairman of the Section of Haemato-Oncology
Unravelling the causes of childhood leukaemia
Dr Kevin Harrington
Targeted Therapy Team Leader
Working to improve treatment for head and neck and skin cancers
Professor Alan Horwich
Section of Radiotherapy Chairman and Academic Dean
Setting new directions in research and education
Dr Robert Huddart
Reader in Urological Oncology
Improving treatments for bladder and testicular cancer
Dr Chris Jones
Paediatric Molecular Pathology Team Leader
Investigating the genetics of children’s cancer
Dr Claus Jørgensen
Cell Communication Team Leader
Investigating the biological steps of cancer development
Professor Stan Kaye
Drug Development Unit Head
Responsible for more than 30 new drug trials
Professor Martin Leach
Co-director of the Cancer Research UK and EPSRC Cancer Imaging Centre at The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust
Using new imaging technology to diagnose cancer and assess patients’ response to treatment
Professor Richard Marais
Signal Transduction Team Leader
Investigating causes and novel treatments of skin cancer
Dr Chris Parker
Senior Lecturer and Clinical Oncologist
Assessing and improving prostate cancer treatment
Professor Andrew Pearson
Paediatric Oncology Section Chairman
Head of the paediatrics research team
Professor David H. Phillips
Professor of Environmental Carcinogenesis
Investigates the environmental causes of cancer and human exposure to carcinogens
Dr Liz Rapley
Scientific Spokesperson
Raising awareness of cancer and the ICR’s groundbreaking research
Professor Caroline Springer
Professor of Biological Chemistry
Developing new drugs that specifically target cancer cells
Professor Anthony Swerdlow
Head of the Epidemiology Section and Director of the Cancer Screening Evaluation Unit
Investigating the causes of cancer
Professor Paul Workman
Head of The Cancer Research UK Centre for Cancer Therapeutics at the ICR
Discoverer of a number of cancer drugs that have progressed to the clinic and head of the ICR's world leading drug development team
